Bridger Management, LLC Natera, Inc. Transaction History

Bridger Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$30.32 - $91.33 $9.5 Million - $28.6 Million	-313,320 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $6.93 Million - $9.56 Million	-80,300 Reduced 20.4%	313,320 $29.3 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $430,250 - $598,600	5,000 Added 1.29%	393,620 $44.7 Million
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $28.9 Million - $39.2 Million	-315,430 Reduced 44.8%	388,620 $39.5 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $40.8 Million - $68.4 Million	-612,002 Reduced 46.5%	704,050 $70.1 Million
Q3 2020 Nov 16, 2020	SELL	$45.89 - $72.67 $6.32 Million - $10 Million	-137,655 Reduced 9.47%	1,316,052 $95.1 Million
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $2.67 Million - $5.04 Million	-101,101 Reduced 6.5%	1,453,707 $72.5 Million
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $5.22 Million - $12.1 Million	302,062 Added 24.11%	1,554,808 $46.4 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $40.2 Million - $50.6 Million	1,252,746 New	1,252,746 $42.2 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.